DELPHARM LILLE

𝐎𝐧 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲 𝟒, 𝐖𝐨𝐫𝐥𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐃𝐚𝐲, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐰𝐨𝐮𝐥𝐝 𝐥𝐢𝐤𝐞 𝐭𝐨 𝐫𝐞𝐚𝐟𝐟𝐢𝐫𝐦 𝐢𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐚𝐟𝐟𝐞𝐜𝐭𝐞𝐝 𝐛𝐲 𝐜𝐚𝐧𝐜𝐞𝐫. Today, one in every six deaths is attributed to a form of cancer, making it one of the world's leading causes of death. Cancer must be fought with strength, and #Delpharm and its associates have understood this and are striving to bring solutions to the patients affected. Delpharm would like to thank DELPHARM LILLE for its contribution to the production of treatments for prostate, breast and leukemia cancers. As well as DELPHARM NOVARA site for its contribution to cancer treatments and DELPHARM MEPPEL for the production of treatment for acute myeloid leukemia. Improving the health and quality of life of cancer patients is our priority. #CDMO #healthcare

𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐀𝐜𝐚𝐝𝐞𝐦𝐲 𝐢𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐡𝐞𝐚𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐞𝐦𝐩𝐥𝐨𝐲𝐞𝐞 𝐭𝐫𝐚𝐢𝐧𝐢𝐧𝐠 𝐚𝐧𝐝 𝐚 𝐤𝐞𝐲 𝐩𝐢𝐥𝐥𝐚𝐫 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲. We are committed to supporting our teams in developing their skills, so that together we can build excellence and meet the challenges of tomorrow. Here are the remarkable results of our commitment in 2024: +195 face-to-face sessions, with an exceptional satisfaction rating of 4.7/5 +1,000 digital modules completed 11 new training programs designed   These figures testify of our determination to train, innovate and develop everyone's potential. #Delpharm #healthcare #humanresources

DELPHARM LILLE, 𝐲𝐨𝐮𝐫 𝐞𝐱𝐩𝐞𝐫𝐭 𝐢𝐧 𝐡𝐨𝐫𝐦𝐨𝐧𝐞 𝐭𝐚𝐛𝐥𝐞𝐭𝐬 For decades, the Lille site has been supporting you in the manufacture and packaging of hormonal tablets. To continue to meet your needs, #Delpharm has invested in a new state-of-the-art fully automatic PVC-ALU blister packaging line, with serialization and aggregation online. This line can be customized according to your requirements such as complex packaging items (calendar, pockets) or multi-phase filling with different tablets in the same blister. For more information contact us here: https://lnkd.in/dwn_qsp #healthcare #investing

𝐅𝐨𝐫 𝐭𝐡𝐞 𝐖𝐨𝐫𝐥𝐝 “𝐓𝐡𝐚𝐧𝐤 𝐘𝐨𝐮” 𝐃𝐚𝐲, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐰𝐨𝐮𝐥𝐝 𝐥𝐢𝐤𝐞 𝐭𝐨 𝐭𝐚𝐤𝐞 𝐭𝐡𝐢𝐬 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐭𝐨 𝐰𝐚𝐫𝐦𝐥𝐲 𝐭𝐡𝐚𝐧𝐤 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐭𝐞𝐚𝐦𝐬 𝐚𝐜𝐫𝐨𝐬𝐬 𝐭𝐡𝐞 𝐧𝐞𝐭𝐰𝐨𝐫𝐤 𝐰𝐡𝐨 𝐜𝐨𝐧𝐭𝐫𝐢𝐛𝐮𝐭𝐞 𝐝𝐚𝐢𝐥𝐲 𝐭𝐨 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐲'𝐬 𝐬𝐮𝐜𝐜𝐞𝐬𝐬. Thanks to their expertise, commitment and passion, #Delpharm continues to develop and innovate to meet the needs of its partners and customers. Thank you for your hard work, dedication and team spirit, which make Delpharm a company proud of its operating principles and achievements. Together, we are building a solid future, driven by a shared ambition: “The one stop shop CDMO serving customers over the time." #healthcare #humanresources

A DELPHARM LILLE, nous avons commencé 2025 en accueillant les étudiants du Master 2 "Pharmacie Galénique Industrielle", de la faculté de Pharmacie de Lille. Après une présentation du groupe Delpharm, de notre site, et de nos métiers, ils ont pu visiter l'usine : la fabrication des médicaments, le conditionnement, le laboratoire de contrôle... Encore et toujours, merci à UFR3S - Département de Pharmacie - Université de Lille, à Juergen Siepmann et Florence Siepmann pour notre partenariat, Merci aux étudiants pour leur intérêt pour nos activités, Et merci à Anne-Lise Wautelet, encore et toujours, de faire découvrir notre usine aux jeunes ! #Delpharm #DelpharmLille #Pharmacie

𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐢𝐬 𝐩𝐫𝐨𝐮𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐚𝐭 𝟐 𝐨𝐟 𝐢𝐭𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬 𝐡𝐚𝐯𝐞 𝐛𝐞𝐞𝐧 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐚𝐬 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐅𝐫𝐚𝐧𝐜𝐞 𝟐𝟎𝟑𝟎 𝐩𝐥𝐚𝐧 𝐭𝐨 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐭𝐡𝐞 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐭𝐨 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐅𝐫𝐚𝐧𝐜𝐞'𝐬 𝐬𝐨𝐯𝐞𝐫𝐞𝐢𝐠𝐧𝐭𝐲. At DELPHARM LILLE, the investment will increase production capacity for oncology medicines. The DELPHARM TOURS site, meanwhile, will secure its ampoule production capacity for essential medicines such as NRBC medicines (Nuclear, radiological, biological and chemical) in the event of health crisis. These two projects require an investment of €20 million, including €3 million subsidised by the French government. 👉 More information here: https://lnkd.in/dfg2wH_r #Delpharm #investing #France2030

#DelpharmLille #Pulls Chez DELPHARM LILLE, nous avons choisi ce mardi 10 décembre pour sortir nos pulls de Noël ! A cette occasion, nous avons partagé notre traditionnel repas de Noël, et affiché nos plus "beaux" pulls. Merci aux collaborateurs qui se sont prêtés au jeu et ont mis du rouge et vert dans notre journée !

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐃𝐄𝐋𝐏𝐇𝐀𝐑𝐌 𝐋𝐈𝐋𝐋𝐄 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞 𝐢𝐧 𝐇𝐢𝐠𝐡 𝐏𝐨𝐭𝐞𝐧𝐭 𝐬𝐨𝐥𝐢𝐝 𝐝𝐨𝐬𝐚𝐠𝐞 𝐟𝐨𝐫𝐦𝐬 𝐮𝐩 𝐭𝐨 𝐎𝐄𝐁 𝟓. With its industrial facilities, #Delpharm can provide solutions for your tablet and capsule manufacturing projects, as well as blister and plastic bottle packaging. 👉 For more information, contact us here: https://lnkd.in/dwn_qsp #healthcare #cdmo

𝐓𝐨 𝐦𝐚𝐫𝐤 𝐭𝐡𝐞 𝐦𝐨𝐧𝐭𝐡 𝐨𝐟 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐰𝐨𝐮𝐥𝐝 𝐥𝐢𝐤𝐞 𝐭𝐨 𝐫𝐞𝐚𝐟𝐟𝐢𝐫𝐦 𝐢𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐚𝐥𝐥 𝐦𝐞𝐧 𝐬𝐮𝐟𝐟𝐞𝐫𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫. Prostate cancer is the most common male cancer in 96 countries, so access to effective treatment is vital to ensure that patients receive the best possible care. #Delpharm is mobilized for this cause, and would like to thank the DELPHARM LILLE and Delpharm Novara sites for their commitment to the production of prostate cancer treatments. Moreover, during this month, Delpharm employees have been made aware of this disease through conferences. 𝐼𝘮𝑝𝘳𝑜𝘷𝑖𝘯𝑔 𝑝𝘢𝑡𝘪𝑒𝘯𝑡𝘴' ℎ𝘦𝑎𝘭𝑡𝘩 𝘢𝑛𝘥 𝘲𝑢𝘢𝑙𝘪𝑡𝘺 𝘰𝑓 𝑙𝘪𝑓𝘦 𝘪𝑠 𝑜𝘶𝑟 𝑝𝘳𝑖𝘰𝑟𝘪𝑡𝘺. #healthcare #movember #cdmo

𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐬𝐞𝐜𝐮𝐫𝐞𝐬 𝐜𝐨𝐫𝐭𝐢𝐜𝐨𝐢𝐝𝐬 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐢𝐧 𝐅𝐫𝐚𝐧𝐜𝐞. Today, #Delpharm has inaugurated a new, fully automated, high-speed packaging line at DELPHARM LILLE to improve the availability of corticoids for French patients.   As part of a strategy to modernise the site, an investment of €5.3 million has been approved, supported by the French government through the ‘France Relance’ investment programme, which has authorised Bpifrance to grant Delpharm a subsidy of €3.6 million.    By increasing its capacity from 8 to 20 million boxes a year, Delpharm will secure availability of corticoids for French patients.   Delpharm continues its commitment to French’s healthcare sovereignty. #investing #francerelance #cdmo